Animal Antibiotics Market
Animal Antibiotic Market Study by Tetracyclines, Penicillins, and Macrolides for Poultry Farms and Dairy Farms From 2024 to 2034
Analysis of Animal Antibiotics Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Animal Antibiotic Market Outlook (2024 to 2034)
The global animal antibiotic market is approximated to generate a revenue of US$ 6.61 billion in 2024 and is further projected to advance at a CAGR of 12% to reach a size of US$ 20.46 billion by the end of 2034.
The demand for products derived from animals, such as eggs, milk, meat, and others is continuously growing worldwide, which is increasing the need for livestock antibiotics to maintain the productivity and health of animals, particularly in large-scale farming operations. Farms are increasingly using high-density animal husbandry techniques to satisfy demand.
Antibiotics are widely used to prevent and manage disease because these settings often enhance the possibility of disease transmission among animals. The significance of animal health is brought to light by outbreaks of zoonotic infections, which are illnesses that pass from animals to people.
Demand is also increasing because of the critical function antibiotics play in managing these infections in animal populations. Latest livestock farming is finding antibiotics with focused pathogen activity more appealing due to ongoing research and development in veterinary drugs. Growth is also aided by innovations in delivery and diagnostics, which increase treatment precision and decrease abuse.
The North American region is analyzed to account for 33.7% of the worldwide animal antibiotic market in 2024. There are stringent regulations on the use of antibiotics in animals, particularly for growth promotion, especially in the United States. The necessity to avoid sickness in animals keeps the demand for therapeutic antibiotics constant despite regulatory limitations.
In this region, better biosecurity practices and antibiotic substitutes are receiving more attention. The market in East Asia is forecasted to expand at 12.7% CAGR over the next ten years because of the growing livestock industries and strong demand for animal protein.
Based on product type, the demand for tetracyclines is approximated at US$ 9.04 billion by 2034 as they are becoming more popular for treating several bacterial illnesses in animals, especially livestock, mainly because of their broad-spectrum effectiveness and low cost.
Tetracyclines are useful for treating intestinal, urinary, and respiratory infections because they work against both gram-positive and gram-negative bacteria. Tetracyclines are used more to maintain animal health and stop the spread of disease in heavily populated farming situations as livestock farming intensifies worldwide to satisfy the growing demand for animal feed.
| Report Attribute | Detail |
|---|---|
| Report Attribute | Detail |
| Animal Antibiotic Market Size (2024E) | US$ 6.61 Billion |
| Forecasted Market Value (2034F) | US$ 20.46 Billion |
| Global Market Growth Rate (2024 to 2034) | 12% CAGR |
| North America Market Share (2024E) | 33.7% |
| Western Europe Market Value (2024E) | US$ 1.5 Billion |
| South Asia & Pacific Market Growth Rate (2024 to 2034) | 14.3% CAGR |
| Poultry Farms Segment Value (2034F) | US$ 10.18 Billion |
| Tetracyclines Segment Value (2034F) | US$ 9.04 Billion |
| Key Companies Profiled | Huvepharma AD;; Merck & Co., Inc.;; Ceva Animal Health LLC;; Zoetis, Inc.;; Crystal Pharma and; Afrivet; Elanco Animal Health; Dechra Pharmaceuticals; Phibro Animal Health; Zoetis; Merck Animal Health; Virbac; Ceva Santé Animale |
Animal antibiotics are used by farmers to prevent animals from suffering from infectious diseases. They are added to animal feed to improve its efficiency as well as promote the growth of animals. The addition of animal antibiotics, such as tetracycline and penicillin to the chicken feed improves egg production and hatchability without causing any mortality.
Moreover, penicillin is used for the treatment of pneumonia in cattle. Animals suffer from bacterial infections just like human beings. They need to be cared for and given time just like we do for our children. Animal antibiotics are used to prevent the disease from being established. It is important to know that the excess of anything is bad, and antibiotics are used either for the treatment of diseases or for their prevention.
Animal antibiotics are gaining ground in case of prevention and treatment of diseases in animals, primarily bacterial diseases. Antibiotics have evolved to be highly instrumental in treating dangerous and contagious diseases, which leads to a reduction of medicines intake in the latter stages of suffering.
The use of animal antibiotics has emerged to be highly imperative in the animal welfare program, which is boosting the adoption rate of animal antibiotics. The high-scale implementation of ‘prevention is better than cure in the field of animal welfare is pushing the vigor of animal antibiotics.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What are the factors that drive the growth of the Animal antibiotic market?
Animal antibiotics are driving the market due to the growing need to improve the efficiency, growth rate, and reproducibility of animals to fulfill the ever-increasing needs of the human population. The cost of maintaining animals is high, hence animal antibiotics are required to prevent diseases in animals. It is important to know whether an animal is suffering from any disease.
Furthermore, increased demand for dairy products and meat is driving the usage of animal antibiotics. However, due to changes in lifestyle and habits, there is an increase in the number of lactose-intolerant people. In addition, the conversion of non-vegetarians into vegetarians is affecting the growth of the animal antibiotic market.
Veterinarians and farmers are joining hands and working together to create health management programs to spread awareness about the prevention of diseases before they develop and spread. However, the World Health Organization (WHO) has recommended that food industries and farmers should reduce the routine usage of animal antibiotics to prevent antibiotic resistance to aid the healthy growth of animals as well as for the prevention of diseases.
What are the challenges associated with the use of animal antibiotics?
There are concerns associated with animal antibiotics, which are resulting in antibiotic resistance in the long term. The repetitive usage of antibiotics and prevention of diseases in animals often result in medicines that lead to resistance. The better use of vaccination and improved hygiene are the key concerns of farmers and animal antibiotic producers.
The food-producing animals are carriers of pathogens, which are latterly transmitted from animals to humans, which cause long-term illnesses and impel to food-borne diseases. Veterinarians recommend the use of less concentrated animal antibiotics in animal treatments across the globe.
The presence of stringent government regulations is creating hurdles for manufacturers to meet set quality standards. The global market for animal antibiotics is expected to witness moderate growth over the forecast period. Antibiotics keep the animals and the environment healthy. When animals suffer from diseases and are left untreated, they require more food and water, whereas healthy animals require fewer natural resources.
However, due to the misuse of drugs, they have entered the human food chain, which is causing antibiotic-resistant infections. Farmers and all those who domesticate animals for any purpose have a moral duty to protect them and take care of them, which includes the cautious use of antibiotics when the animals are suffering from diseases.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Segment wise Insights
Based on product type, the animal antibiotic market is segmented into penicillin, sulphonamides, and tetracyclines. In 2020, the share of tetracycline is dominant among all types accounting share of 48% in total sales. This tetracycline is widely used owing to its highest potency against pathogenic microbes.
The advantage of this product helps in acquiring a large share of product segments. Moreover, there is an anticipated rise in fluoroquinolones during the assessment period of this research owing to their efficiency during low concentration. These antibiotics are quick to penetrate through the tissues and are highly adopted by end users.
The premixes segment in terms of delivery modes dominated the animal antibiotic market. These are further categorized into oral solutions and injections. The premix segment owned a share of 45% in 2020. A large share of this segment is attributed to benefits and modes of administration. This segment is expected to see growth in upcoming years.
Regional Insights
The global animal antibiotic market is segmented into North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan, and the Middle East & Africa (MEA). North America is expected to dominate the global animal antibiotic market owing to the widespread availability of technological advancements and medical care.
The animal antibiotic market in Asia Pacific excluding Japan is expected to grow at a significant CAGR due to the expansion of product offerings by key players. Europe is expected to have the second-largest share in the global animal antibiotic market throughout the forecast period.
As per FAO South Asia is a major dairy production region in the world accounting for one-fourth of global dairy products. India is the largest country in Asia Pacific in terms of dairy production followed by China. To maintain the livestock qualities and minimize the risk of diseases among animals, the animal husbandry industry in this region is dependent on animal antibiotics as health improvement products.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Segmentation of Animal Antibiotic Market Research
-
By Product Type :
- Tetracyclines
- Penicillins
- Macodolides
-
By End User :
- Poultry Farms
- Dairy Farms
- Other Livestock Farms
-
By Application :
- Interfacility
- Rescue Helicopter Services
- Organ Transplant Logistics
- Scene Response
-
By Region :
- North America
- Western Europe
- Eastern Europe
- Latin America
- East Asia
- South Asia & Pacific
- Middle East & Africa
Table of Content
- 1. Executive Summary
- 2. Industry Introduction, including Taxonomy and Market Definition
- 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
- 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections
- 5. Pricing Analysis
- 6. Global Market Analysis and Forecast
- 6.1. Product Type
- 6.2. End Users
- 7. Global Market Analysis and Forecast, By Product Type
- 7.1. Tetracyclines
- 7.2. Penicillins
- 7.3. Macrolides
- 8. Global Market Analysis and Forecast, By End Users
- 8.1. Poultry Farm
- 8.2. Dairy Farm
- 8.3. Other Livestock Farm
- 9. Global Market Analysis and Forecast, By Region
- 9.1. North America
- 9.2. Latin America
- 9.3. Western Europe
- 9.4. Eastern Europe
- 9.5. East Asia
- 9.6. South Asia & Pacific
- 9.7. MEA
- 10. North America Sales Analysis and Forecast, by Key Segments and Countries
- 11. Latin America Sales Analysis and Forecast, by Key Segments and Countries
- 12. Western Europe Sales Analysis and Forecast, by Key Segments and Countries
- 13. Eastern Europe Sales Analysis and Forecast, by Key Segments and Countries
- 14. East Asia Sales Analysis and Forecast, by Key Segments and Countries
- 15. South Asia & Pacific Sales Analysis and Forecast, by Key Segments and Countries
- 16. MEA Sales Analysis and Forecast, by Key Segments and Countries
- 17. Sales Forecast by Product Type and End Users for 30 Countries
- 18. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
- 19. Company Profile
- 19.1. Huvepharma AD
- 19.2. Merck & Co., Inc.
- 19.3. Ceva Animal Health LLC
- 19.4. Zoetis, Inc.
- 19.5. Crystal Pharma
- 19.6. Afrivet
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Market US$ Bn Forecast by Region
Table 2: Global Market US$ Bn Forecast by Product Type
Table 3: Global Market US$ Bn Forecast by End Users
Table 4: North America Market US$ Bn Forecast by Country
Table 5: North America Market US$ Bn Forecast by Product Type
Table 6: North America Market US$ Bn Forecast by End Users
Table 7: Latin America Market US$ Bn Forecast by Country
Table 8: Latin America Market US$ Bn Forecast by Product Type
Table 9: Latin America Market US$ Bn Forecast by End Users
Table 10: Western Europe Market US$ Bn Forecast by Country
Table 11: Western Europe Market US$ Bn Forecast by Product Type
Table 12: Western Europe Market US$ Bn Forecast by End Users
Table 13: Eastern Europe Market US$ Bn Forecast by Country
Table 14: Eastern Europe Market US$ Bn Forecast by Product Type
Table 15: Eastern Europe Market US$ Bn Forecast by End Users
Table 16: East Asia Market US$ Bn Forecast by Country
Table 17: East Asia Market US$ Bn Forecast by Product Type
Table 18: East Asia Market US$ Bn Forecast by End Users
Table 19: South Asia & Pacific Market US$ Bn Forecast by Country
Table 20: South Asia & Pacific Market US$ Bn Forecast by Product Type
Table 21: South Asia & Pacific Market US$ Bn Forecast by End Users
Table 22: MEA Market US$ Bn Forecast by Country
Table 23: MEA Market US$ Bn Forecast by Product Type
Table 24: MEA Market US$ Bn Forecast by End Users
Table 25: Latin America Market US$ Bn Forecast by Country
Table 26: Latin America Market US$ Bn Forecast by Product Type
Table 27: Latin America Market US$ Bn Forecast by End Users
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Product Type
Figure 2: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End Users
Figure 3: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Region
Figure 4: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Product Type
Figure 5: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End Users
Figure 6: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country
Figure 7: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Product Type
Figure 8: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End Users
Figure 9: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country
Figure 10: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Product Type
Figure 11: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End Users
Figure 12: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country
Figure 13: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Product Type
Figure 14: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End Users
Figure 15: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country
Figure 16: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Product Type
Figure 17: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End Users
Figure 18: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country
Figure 19: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Product Type
Figure 20: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End Users
Figure 21: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country
Figure 22: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Product Type
Figure 23: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End Users
Figure 24: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country
Figure 25: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Product Type
Figure 26: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End Users
Figure 27: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the future market outlook for the animal antibiotic market?
The market is further evaluated to surpass a valuation of US$ 20.46 billion by the end of 2034.
What is the projected growth rate for the animal antibiotic market?
The animal antibiotic market is analyzed to grow with a CAGR of 12% in the forecast period.
How big is the animal antibiotic market at present?
The global animal antibiotic market is valued at US$ 6.61 billion in 2024.
Which type of mode is leading in the product delivery segment?
Premixes are dominating the mode of delivery of the animal antibiotic market.
Which geographical region is dominating the animal antibiotics arcade?
North America accounts for a major share of animal antibiotics arcade.
Animal Antibiotics Market